41 - 50 out of 340Page size: 10
  1. 2019

  2. Limited data to evaluate real-world effectiveness of enzyme replacement therapy for mucopolysaccharidosis type I

    Kuiper, G-A., Nijmeijer, S. C. M., Roelofs, M. J. M., van der Lee, J. H., Hollak, C. E. M. & Bosch, A. M., Sep 2019, In: Journal of inherited metabolic disease. 42, 5, p. 762-775

    Research output: Contribution to journal › Review article › Academic › peer-review

  3. The Mini Mental State Examination does not accurately screen for objective cognitive impairment in Fabry Disease

    Körver, S., van de Schraaf, S. A. J., Geurtsen, G. J., Hollak, C. E. M., van Schaik, I. N. & Langeveld, M., Jul 2019, In: JIMD reports. 48, 1, p. 53-59 7 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  4. Antibodies against recombinant alpha-galactosidase A in Fabry disease: Subclass analysis and impact on response to treatment

    van der Veen, S. J., van Kuilenburg, A. B. P., Hollak, C. E. M., Kaijen, P. H. P., Voorberg, J. & Langeveld, M., Feb 2019, In: Molecular genetics and metabolism. 126, 2, p. 162-168 7 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  5. Long-term treatment effect in cerebrotendinous xanthomatosis depends on age at treatment start

    Stelten, B. M. L., Huidekoper, H. H., van de Warrenburg, B. P. C., Brilstra, E. H., Hollak, C. E. M., Haak, H. R., Kluijtmans, L. A. J., Wevers, R. A. & Verrips, A., 8 Jan 2019, In: Neurology. 92, 2, p. e83-e95

    Research output: Contribution to journal › Article › Academic › peer-review

  6. Bizarre behavior and decreased level of consciousness in an adult patient

    van Son, J., Rietbroek, R. C., Vaz, F. M. & Hollak, C. E. M., Jan 2019, In: Netherlands journal of medicine. 77, 1, p. 25-28 4 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  7. zorgpad voor HMG-CoA-lyasedeficiëntie

    Timmer, C., Hollak, C. E. M., Verhagen, M., Huidekoper, H., Hollak, P. & Dekker, H., Jan 2019, 34 p.

    Research output: Other contribution › Professional

  8. Dose-Finding Studies Among Orphan Drugs Approved in the EU: A Retrospective Analysis

    Schuller, Y., Gispen-de Wied, C., Hollak, C. E. M., Leufkens, H. G. M. & Stoyanova-Beninska, V., 2019, In: Journal of clinical pharmacology. 59, 2, p. 229-244

    Research output: Contribution to journal › Article › Academic › peer-review

  9. Liposome-targeted recombinant human acid sphingomyelinase: Production, formulation, and in vitro evaluation

    Aldosari, M. H., de Vries, R. P., Rodriguez, L. R., Hesen, N. A., Beztsinna, N., van Kuilenburg, A. B. P., Hollak, C. E. M., Schellekens, H. & Mastrobattista, E., 2019, In: European journal of pharmaceutics and biopharmaceutics. 137, p. 185-195

    Research output: Contribution to journal › Article › Academic › peer-review

  10. Patients With Aldolase B Deficiency Are Characterized by Increased Intrahepatic Triglyceride Content

    Simons, N., Debray, F-G., Schaper, N. C., Kooi, M. E., Feskens, E. J. M., Hollak, C. E. M., Lindeboom, L., Koek, G. H., Bons, J. A. P., Lefeber, D. J., Hodson, L., Schalkwijk, C. G., Stehouwer, C. D. A., Cassiman, D. & Brouwers, M. C. G. J., 2019, In: Journal of clinical endocrinology and metabolism. 104, 11, p. 5056-5064

    Research output: Contribution to journal › Article › Academic › peer-review

  11. Predictors of objective cognitive impairment and subjective cognitive complaints in patients with Fabry disease

    Körver, S., Geurtsen, G. J., Hollak, C. E. M., van Schaik, I. N., Longo, M. G. F., Lima, M. R., Vedolin, L., Dijkgraaf, M. G. W. & Langeveld, M., 2019, In: Scientific reports. 9, 1, 188.

    Research output: Contribution to journal › Article › Academic › peer-review

Previous 1 2 3 4 5 6 7 8 ...34 Next

ID: 61215